The Board denied earlier effective dates for the assignment of a 30 percent rating for degenerative joint disease right knee and left anterior cruciate ligament tear and medial collateral ligament tear with chronic anterior cruciate insufficiency.
The deciding factor: The increase in disability was not factually ascertainable prior to the current effective dates of April 5, 2022, and May 2, 2022, respectively.
- Claimed conditions
- Degenerative joint disease right knee, Left anterior cruciate ligament tear and medial collateral ligament tear with chronic anterior cruciate insufficiency
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- May 12, 2025
- Citation
- A25042272
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's service-connected disabilities, including back, knee, and foot conditions, prevent him from securing or following any substantially gainful occupation.
- Granted
The Board granted service connection for obstructive sleep apnea, effective from the date of the February 2025 rating decision.
- Remanded (sent back)
The Board remands the claim for a medical examination to determine if the Veteran's current neck strain is related to his in-service activities.
- Remanded (sent back)
The Board remands the claim for a rating in excess of 70 percent for PTSD due to an inadequate medical opinion.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.